1 – 3 of 3
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2024
-
Mark
Outlining recent updates on influenza therapeutics and vaccines : A comprehensive review
(
- Contribution to journal › Scientific review
- 2023
-
Mark
PARP14 is a PARP with both ADP-ribosyl transferase and hydrolase activities
(
- Contribution to journal › Article
- 2020
-
Mark
A phase 2 randomized, double-blind, placebo-controlled trial of MHAA4549A, a monoclonal antibody, plus oseltamivir in patients hospitalized with severe influenza a virus infection
(
- Contribution to journal › Article